SBIOALPS Medical Breakthroughs ETF
Grow my money#1092 of 2944 for Grow my money
Seeks investment results that correspond to the performance of the S-Network Medical Breakthroughs Index.
ALPS · Since 2014 (11 years)
Annual Cost
0.50%
#2384 out of 5,332 ETFs
Fund Size
$132M
#2492 out of 5,332 ETFs
Dividend Yield
0.00%
Track Record
11 years
#1270 out of 5,332 ETFs
Performance
1 Year
+80.4%
3 Years
+23.3%
5 Years
+1.9%
What's inside
Asset class
Region
Focus
Biotech & Genomics
Asset allocation
Stocks
100.0%
Sector breakdown
Healthcare
100.0%
Top holdings
Kymera Therapeutics Inc Ordinary SharesKYMR4.2%
Alkermes PLCALKS3.6%
CG Oncology IncCGON3.5%
Mirum Pharmaceuticals IncMIRM3.4%
Celcuity IncCELC3.3%
Apellis Pharmaceuticals IncAPLS3.2%
Xenon Pharmaceuticals IncXENE3.0%
Apogee Therapeutics IncAPGE2.9%
Amicus Therapeutics IncFOLD2.8%
Spyre Therapeutics IncSYRE2.4%
Risk profile
Volatility (1Y)
30.1%
High
Max drawdown
-63.1%
Worst peak-to-trough loss
Sharpe (3Y)
0.73
Decent risk-adjusted returns
Sortino (3Y)
1.07
Good downside protection
Similar ETFs
Data updated on 2026-05-05